Source: Cytel Blog

Cytel Blog Bayesian Methods for Strategic Clinical Trial Design

  “There is always the risk that interim analyses might occur after the Sufficient Information Threshold has been reached. Bayesian methods alleviate some of this risk.”

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
1.0-5.0K
Joshua Schultz's photo - CEO of Cytel

CEO

Joshua Schultz

CEO Approval Rating

91/100

Read more